Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative

doi:10.3748/wjg.v26.i19.2416

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8026)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

505

WORD

187

HTML

4465

Figures (1-2)

258

Tables (1-3)

237

Sum=5652

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

731

Download

1643

Sum=2374

May 21, 2020 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. May 21, 2020; 26(19): 2416-2426
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2416

Full Size Figure Download Figure

Figure 2 Scatter plot of baseline gamma-glutamyl transferase levels and QRISK2 scores found no correlation (r = 0. 022, P = 0.463). CVD: Cardiovascular disease; GGT: Gamma-glutamyl transferase.

Citation: Pitisuttithum P, Chan WK, Goh GBB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Dan YY, Imajo K, Nakajima A, Ho KY, Goh KL, Wong VWS, Treeprasertsuk S. Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative. World J Gastroenterol 2020; 26(19): 2416-2426
URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2416.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2416